SAH-p53-8

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSAH-p53-8
Drug Alias Namehydrocarbon-stapled alpha-helical p53 peptide (Aileron Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of Actionp53-binding protein Mdm-2 inhibitorsTumor protein p53 stimulantsProtein Mdm4 inhibitors
TargetsProtein Mdm4Tumor protein p53p53-binding protein Mdm-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRein Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRein Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A